Inactive Instrument
Checkmate Pharmaceuticals, Inc. Share Price
Stocks
CMPI
US1628181083
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 12/12/2018 | |
Robert Landry
DFI | Director of Finance/CFO | 62 | 31/05/2022 |
Chris French
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 31/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/05/22 | Issuer sale | Director | 36,778 | 0.1700% | ||
| 31/05/22 | Issuer sale | Chief Financial Officer | 2,78,480 | 1.2874% | ||
| 31/05/22 | Issuer sale | Chief Executive Officer | 2,79,437 | 1.2919% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.38% | - | - | 23Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | |
| -3.11% | -3.53% | +20.19% | +81.44% | 5.74TCr | |
| +0.89% | -0.63% | +2.17% | +36.19% | 4.76TCr | |
| +0.36% | +0.81% | +342.39% | +742.40% | 4.43TCr | |
| -0.96% | -4.50% | +24.96% | +35.38% | 4.25TCr | |
| -0.20% | -0.77% | +4.13% | +105.50% | 4.07TCr | |
| -0.54% | +2.93% | +9.31% | +50.41% | 3.1TCr | |
| -2.68% | +2.92% | +29.33% | +22.72% | 2.85TCr | |
| +0.05% | -1.64% | -8.14% | -11.37% | 2.43TCr | |
| Average | -0.20% | -0.59% | +52.63% | +128.54% | 4.34TCr | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.96% | +138.26% |
Employees
31
